Bayer will start the Integration of Monsanto

0
375

After the chemical giant Bayer with the sale of a business division to a competitor, BASF, a last edition has been met, you can now start the Integration of the new acquisition, Monsanto – and, indeed, in the case of a strong headwind.

The chemical company Bayer loses to Report on further actions against Monsanto in the USA, massively. On Thursday morning, the share price of the Bayer group, has acquired the US-based company, more than five per cent in the Minus. Thus, the paper has lost since last Friday, a fifth of its stock market value.

Previously, the “economic reports of the week” that U.S. farmers have filed a lawsuit because of the herbicide, Dicamba. The weed killer is used in genetically modified plants, but is suspected of damage in conventionally-planted neighbouring fields to inflict.

The editorial recommends

The agricultural group Monsanto has been sentenced to a million payment because of its glyphosate-containing herbicides are supposed to have caused cancer. For the Bayer, a subsidiary of a shock. The judgment can have consequences. (11.08.2018)

Rate fall of the Bayer stock: The investors are shell-shocked after a conviction is too high damages in connection with a glyphosate-containing weed killer in the new US subsidiary of Monsanto. (13.08.2018)

Accompanied by protests, the discussions in Brussels about the future of the controversial weed ester of destruction started to glyphosate. A ban would make use of German chemical companies, rather than harm. (18.05.2016)

It is carried out: The controversial Monsanto and heard since Thursday fully to Bayer. The Takeover had been successfully completed. Bayer promises of Social and environmental standards. (07.06.2018)

Bayer’s share had already received on Monday a heavy blow after a court in the United States had condemned the agricultural company Monsanto to pay $ 290 million to the cancer caretaker Dewayne Johnson. This attributed his disease to the herbicide glyphosate, Monsanto denies a connection. Thousands more cancer patients will have have filed suit against Monsanto.

Bayer and Monsanto want to fight together

Monsanto had previously announced an appeal against the judgment. Bayer may turn on after the Acquisition of the Monsanto group is now directly in the litigation to the weed killer glyphosate. The companies have now the opportunity to actively participate in the defense in the case of the glyphosate-procedure involved, explained the group on Thursday.

“Glyphosate is not responsible”

In a press release, the Leverkusen-based Bayer group, put his view of things is clear. Bayer is in it “is of the opinion that the decision of the Jury is contrary to existing scientific evidence, decades of practical experience and assessments from regulatory bodies around the world”.

With regard to the outcome of possible further court proceedings, the group is very confident: “Bayer is convinced that the courts will not come in the further course of Proceedings to the conclusion that Monsanto and glyphosate are for the illness of Mr. Johnson, is responsible.”

This controversial glyphosate-containing weed killer from Monsanto could come to Bayer tax.

Integration without and with Bayer’s “Digital Farming” possible

The Leverkusen can now start with the Integration of the acquired the U.S. seed company Monsanto. With the completion of the sale of a business to a German competitor, BASF, the conditions are met, such as Bayer said. The company is already since 7. June is the sole owner of Monsanto.

The concerns of the competition authorities against the 63 billion US dollars (55,6 billion Euro) heavy Monsanto to eliminate the purchase, parted with Bayer, among others, from his vegetable and field seed business, of activities in the area of “Digital Farming”, as well as from the worldwide business with the herbicide Glufosinate-Ammonium.

Bayer continues to expect by 2019 to a positive contribution of Monsanto to the adjusted earnings per share to range from 2021 to double-digit percentage range. By 2022, annual contributions to earnings before interest, taxes, depreciation and amortization (Ebitda) and special items from savings in the course of the Deals in the amount of 1.2 billion US-dollars are planned.

dk/hb (dpa, rtr, afp, Bayer AG)